Article
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC.
Oncotarget - 13 Oct 2015
Occhi Gianluca, Barollo Susi, Regazzo Daniela, Bertazza Loris, Galuppini Francesca, Guzzardo Vincenza, Jaffrain-Rea Marie Lise, Vianello Federica, Ciato Denis, Ceccato Filippo, Watutantrige-Fernando Sara, Bisognin Andrea, Bortoluzzi Stefania, Pennelli Gianmaria, Boscaro Marco, Scaroni Carla, Mian Caterina
Abstract excerpt
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor mediating the toxicity and tumor-promoting properties of dioxin. AHR has been reported to be overexpressed and constitutively active in a variety of solid tumors, but few data are currently available concerning its role in thyroid cancer. In this study we quantitatively explored a series of 51 paired-normal and papillary thyroid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
